Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 26, 2024

Association of SGLT2 Inhibitor Use With Risk of Incident Dementia and All-Cause Mortality in Older Patients With Type 2 Diabetes

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Diabetes Obes Metab 2024 Sep 09;[EPub Ahead of Print], YW Pai, IC Chen, JF Lin, XH Chen, HH Chen, MH Chang, JA Huang, CH Lin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading